Skip to main content
Clinical Trials/NCT01833442
NCT01833442CompletedNot Applicable

Randomized Controlled Meditation Trial for Treating OCD Comparing Kundalini Yoga Meditation Versus the Relaxation Response

University of Sao Paulo1 site in 1 country50 target enrollmentStarted: March 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
The Yale-Brown Obsessive Compulsive Scale (YBOCS)

Study Overview

Brief Summary

The trial objective is to compare two very different meditation protocols (Kundalini Yoga and Relaxation Response meditation techniques) to help the OCD treatment.

Detailed Description

The proposed trial comparing the two different meditation protocols is expected to have two phases: 0-month to 4.5-month period where we compare the Kundalini Yoga protocol with Relaxation Response meditation technique, both on the primary efficacy variable using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and some if not most of the secondary variables using The Dimensional Yale-Brown Obsessive Compulsive Scale (DY-BOCS), Clinical Global Impressions (CGI), Profile of Mood States (POMS), Beck Anxiety Inventory (Beck-A), Beck Depression Inventory (Beck-D), and SF-36 Health Status Questionnaire (SF36). Participants will go to the hospital once a week for a 1,5 hour meditation class.After 4.5-months, all patients will be evaluated and merged together into a single group. Patients will then receive 09 to 12 more months of the meditation protocol. The investigators are expecting to recruit 50 to 60 patients to start. Patients will be blinded to the content of the protocol in the other group at baseline and until one group shows greater efficacy on the primary efficacy variable. The intake physician will be blinded to the treatment groups of the patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Clinical diagnosis of OCD for at least 6 months.
  • A minimum score of 16 on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) for the 10-item total score at the baseline screening will be required.
  • The patient must sign and been provided with a copy of an Assent Form for their reference.

Exclusion Criteria

  • Psychoactive prescription medications other than those prescribed for OCD.
  • Spinal problems, or other physically limiting problems.
  • Clinical diagnosis of hypertension, or other cardiovascular problems.
  • Clinical diagnosis of Parkinson's disease.
  • Clinical diagnosis of major depressive disorder with psychotic features, schizophrenia, bipolar disorder, mental retardation, anorexia nervosa, bulimia nervosa, autistic disorder, Asperger's disorder and other forms of pervasive developmental disorder, or traumatic brain.
  • Clinical diagnosis of Tourette's Syndrome.
  • Patients without regular and reliable transportation to the study site.
  • Patients who choose not to participate in meditation and/or chanting (out loud or silently) for personal or religious reasons.

Arms & Interventions

Kundalini Yoga Meditation

Active Comparator

Kundalini Yoga Meditation is going to be use as therapy for OCD, and it will be compare with Relaxation Response Meditation.

Intervention: Kundalini Yoga Meditation (Behavioral)

Relaxation Response Meditation

Active Comparator

Relaxation Response Meditation is going to be use as therapy for OCD, and it will be compare with Kundalini Yoga Meditation.

Intervention: Relaxation Response Meditation (Behavioral)

Outcomes

Primary Outcomes

The Yale-Brown Obsessive Compulsive Scale (YBOCS)

Time Frame: Up to 16 months

The Yale-Brown Obsessive Compulsive Scale, sometimes referred to as Y-BOCS, is a test to rate the severity of obsessive-compulsive disorder (OCD) symptoms.

Secondary Outcomes

  • The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS)(Up to 16 months)
  • Clinical Global Impressions (CGI)(Up to 16 months)
  • Profile of Mood States (POMS)(Up to 16 months)
  • Beck Anxiety Inventory (Beck-A)(Up to 16 months)
  • Beck Depression Inventory (Beck-D)(Up to 16 months)
  • SF-36 Health Status Questionnaire (SF36)(Up to 16 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Euripedes C. Miguel

Chairmain of psychiatry Departament of University os Sao Paulo

University of Sao Paulo

Study Sites (1)

Loading locations...

Similar Trials